MARJORIE PALMER: Open Payments
NPI 1528741915 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$623 in 25 payments from 8 companies in 2025. Trend: 2023 $60 · 2024 $424 · 2025 $623
Food & beverage: $623
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 15 | $381 |
| Janssen Biotech, Inc. | 3 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $45 |
| PFIZER INC. | 1 | $29 |
| Becton, Dickinson and Company | 1 | $28 |
| Boston Scientific Corporation | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| UROGEN PHARMA, INC. | 1 | $21 |
Products named: GEMTESA, ORGOVYX, ERLEADA, Nubeqa, XTANDI, Magic3 Go Intermittent Urinary Catheter, SpaceOAR VUE System - 10mL, PLUVICTO.
Industry payments across MD — which companies pay providers there.
